CardioComm Solutions, Inc. (CardioComm Solutions) (TSX VENTURE:EKG)

completed a recent interview with the Wall Street Reporter and an

upcoming Ad in USA Today mark the beginning of a Marketing

Communications Campaign in support of the company' entry into the

Health Market with their recently announced Food and Drug

Administration (FDA) clear HeartCheck Pen Hand Held ECG targeted at


In his interview with the Wall Street Reporter Mr. Etienne Grima, CEO,

discussed CardioComm Solution's current direction in the field of

Telemedicine and provided insight into planned initiatives that the

company will be launching over the next 24 months, initiatives

building on proven and stable software products. The interview

highlighted CardioComm Solutions as a software engineering company

that is not dependent on others for software enhancements and

innovations, a company emerging from three years of planning with an

aim to close the gap in providing access for patients and consumers to

qualified medical care.

Francois Paul Thibault, Canadian Designer and Sculpture of Yellow

Knife, NWT, Canada said, "I believe CardioComm's technology will

empower people with direct access to doctors and professional teams at

breakneck wireless internet speeds. This will streamline our health

system to where it should be and reach well beyond. CardioComm's new

wireless propriety software and HeartCheckTM PEN technology will allow

patients and individuals from all areas of the globe to save valuable

time. What CardioComm will offer is the opportunity to save millions

of dollars in medical travel services in regions like the NWT, the

Yukon and Nunavut. Each year hundreds of people fly escorted to large

centers for these types of test at an incredible cost to our

Government and Health Care system. Investing in one of these PEN

devices will save a world of uncertainties, alleviate sleepless nights

and most importantly may save a multitude of lives. Finally the Star

Trek Era is here."

CardioComm Solutions to Co Sponsor Publication for National Heart

Health Month

In keeping with their commitment to patient education and awareness,

CardioComm Solutions, Inc. will be co-sponsoring a major educational

publication and campaign for National Heart Health Month. On February

23rd, 2012, Mediaplanet Publishing, Inc. will be releasing its 5th

edition of "Cardiovascular Health" to be distributed in USA Today in

key regional markets. The publication will stress the importance of

open patient-doctor dialogue and will also address issues around

Atrial Fibrillation. "We thought this would be a great opportunity to

introduce the HeartCheckTM PEN to a consumer audience and discuss how

innovative patient monitoring can help prevent the occurrence of

sudden cardiac events," said Etienne Grima.

"CardioComm Solutions continues to be a significant player in ECG

Management Solutions," noted Mr. Simi Grosman, a member of CardioComm

Solution's Board of Directors, "under the stewardship of Dr. Anatoly

Langer, the company's Chairman of the Board, and CEO Etienne Grima's

business leadership and vision, the company is beginning to see the

results of the last 3 years of continuous product development and

software enhancements."

About CardioComm Solutions

CardioComm Solution's patented and proprietary technology is used in

products for recording, viewing, analyzing and storing

electrocardiograms (ECGs) for diagnosis and management of cardiac

patients. Products are sold worldwide through a combination of an

external distribution network and a North American-based sales team.

The company has earned the ISO 13485 certification, is HPB approved,

HIPAA compliant, and has received FDA market clearance for its

software devices. CardioComm Solutions, Inc. is headquartered in

Toronto, Canada, with offices in Victoria, B.C.

Forward-looking statements

This release may contain certain forward-looking statements with

respect to the financial condition, results of operations and business

of CardioComm Solutions and certain of the plans and objectives of

CardioComm Solutions with respect to these items. By their nature,

forward-looking statements involve risk and uncertainty because they

relate to events and depend on circumstances that will occur in the

future and there are many factors that could cause actual results and

developments to differ materially from those expressed or implied by

these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as

that term is defined in policies of the TSX Venture Exchange) accepts

responsibility for the adequacy or accuracy of this release.